We’re halfway through Movember and so far our MoDAWGs team has recruited 86 members and raised $4,355. So how does that compare with other Mo-Teams in Seattle? Up the street at Amazon they’ve got 1,015 Mo Bros and Sistas who have raised $43K. Starbucks has 134 members who have raised nearly $13K. And Microsoft has 244 members and over $15K raised. That’s a lot of facial hair growing in the Seattle area. Check out MoDAWG leader Dr. Jonathan Wright′s progress month-to-date at right.
This Saturday, Dr. Wright will kickoff a Movember tailgate party before the Oregon State game. If you’re going to the game, be sure to stop by the tailgate with the MoDAWGs banner between lots E15RV and E12 (click on the map at left). Come enjoy mustaches galore, tailgate appetizers like beef sliders and mac and cheese bites, and even a mustache cake! The party starts at 4:30pm, gametime is 7:30. See you there and go Huskies! And if you haven’t yet become a MoDAWG, it’s not too late: signup here.
Listed below are clinical trials that have opened at SCCA in the last several weeks. These trials are looking at new treatments for patients with advanced hepatocellular carcinoma, relapsed or refractory leukemia, myelodysplastic syndromes, and gynecologic cancers including endometrial cancer, ovarian cancer, and primary peritoneal cancer. For more information about these trials, click on the links below. Check out our website to learn about the more than 200 ongoing clinical trials at SCCA. And follow us on Twitter at @SCCA_Trials for information about recently opened trials.
ADI PEG 20 Plus Sorafenib for Advanced Hepatocellular Carcinoma
A Phase 1 Study of ADI PEG 20 Plus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)
Genetically Modified T Cells Directed Against CD19 for Relapsed/Refractory CD19+ Leukemia
Pediatric and Young Adult Leukemia Adoptive Therapy (PLAT)-02: A Phase 1/2 Feasibility and Safety Study of CD19-CAR T Cell Immunotherapy for CD19+ Leukemia
Donor Umbilical Cord Blood Transplant w/wo Ex-Vivo Expanded Cord Blood Progenitor Cells for Leukemia and Myelodysplastic Syndromes (2603)
Multi-center, Open-Label Randomized Study of Single or Double Myeloablative Cord Blood Transplantation With or Without Infusion of Off-The-Shelf Ex Vivo Expanded Cryopreserved Cord Blood Progenitor Cells in Patients With Hematologic Malignancies
Rucaparib as Switch Maintenance Following Platinum-Based Chemotherapy for Gynecological Cancer (9191)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Rucaparib as Switch Maintenance Following Platinum-Based Chemotherapy in Patients with Platinum-Sensitive, High-Grade Serous or Endometrioid Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer
The cold and flu season is upon us, and efforts to protect patients from catching a viral infection have been underway at SCCA for months. Seasonal flu most commonly peaks between December and February, and cancer increases the risk of developing complications from a typical flu virus. The Centers for Disease Control (CDC) recommends that cancer patients, survivors, and caregivers be vaccinated against seasonal flu.
A campaign to vaccinate SCCA staff began in September, and this year nearly 97 percent of the staff received a flu vaccine. Nationally, only 72.5 percent of health care workers were vaccinated against the flu, according to the most recent CDC analysis. Read more about how SCCA has worked to increase its vaccination rates in recent years.
The importance of protecting cancer patients from the flu is underscored in this profile from our partners at Fred Hutch, which includes the story of Bridget Clawson, a breast cancer patient who survived surgery, radiation, and nearly a year of chemotherapy only to end up in the emergency room with a case of viral pneumonia that nearly took her life. Current SCCA patients who have not yet received a flu shot should ask their nurse or doctor about getting one during their next appointment. The SCCA Infection Control team is also a resource for questions from patients, families, and staff.
If you’re looking for more information, check out the CDC’s resources on what you should know about this year’s flu season and frequently asked questions about the flu for cancer patients, survivors, and caregivers. You can even watch the U.S. Surgeon General receive his flu shot. Now is the time to protect yourself against the seasonal flu.
The Fall 2014 issue of Thriving is now available. Thriving is a quarterly newsletter aimed at the needs of cancer survivors. This issue of Thriving includes articles about overcoming chemobrain, the sugar and cancer connection, the benefits of exercise for breast cancer survivors, and spiritual troubles after receiving a bone marrow transplant. You can download a PDF version of Thriving as well as read it online. To receive Thriving in your inbox, visit our newsletter subscription page.
Movember started this week, and by now you’ve probably seen it starting to sprout on the faces of certain men around you (see Dr. Jonathan Wright’s progress at right). If the start of Movember has somehow passed you by, here is some background information and some ideas to help you on your way:
- First off, what is Movember? Movember challenges men to grow moustaches during Movember (the month formerly known as November) to spark conversation and raise funds for men’s health, including prostate cancer, testicular cancer, and mental health problems.
- If you’re reading this blog post, the best way to jump on the Movember bandwagon is to join MoDAWGs by registering here.
- Plan to attend the MoDAWGs tailgate party before the Washington-Oregon State football game on Saturday Nov. 22. Watch this space for more details in the coming weeks!
- Think about what you’ll say when someone asks about your mustache (see #1 above, the whole point of Movember!).
- Questions? Check out the Movember video below: